Search

everythinglearnresearchcommunity

for

Search:↓

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

Melatonin improved mental health and metabolism in women with PCOS.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Alopecia areata significantly impacts patients' mental health and quality of life.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.

Platelet-rich plasma therapy might help treat some kinds of hair loss.

Androgenetic alopecia is more common in male Chinese adolescents and linked to rosacea, but doesn't affect quality of life.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Hair loss can be linked to hormonal changes, and physical conditions like heart defects can cause depression.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

There is no link between hair loss and prostate enlargement.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Multimedia education greatly improves women's knowledge and management of PCOS.

Patients who survive critical illness often face long-lasting physical, mental, and cognitive issues, with many unable to return to work within a year.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.